Guadalupe Hayes-Mota is a healthcare and AI executive, entrepreneur, and policy leader committed to enhancing global medicine accessibility and innovation. He is the founder and CEO of an AI-driven healthcare startup that is transforming drug development and accessibility. Previously, he founded and CEO of Healr Solutions, an AI-powered company that optimized global drug distribution and production, which he successfully exited and sold to investors. With executive experience at Biogen, Amgen, and GSK, Hayes-Mota oversaw intricate supply chain operations, ensuring the efficient manufacturing and delivery of life-saving medicines to billions. His contributions extend to public health policy, including his work on the Affordable Care Act with the Obama administration. Hayes-Mota was appointed by the U.S. Secretary of Health and Human Services to the NIH Cures Acceleration Network Review Board, where he accelerates treatment development impacting millions. He also served in the Massachusetts Rare Disease Advisory Council. His achievements have earned him recognition, with Business Insider naming him one of six powerful LGBTQ+ executives to have on corporate boards, and PharmaVoice listing him as one of the 100 Most Inspiring and Influential People in healthcare and biotechnology.
Unlocking the Future: The Convergence of AI, Personalized Medicine, and Genomics
AI and genomics are revolutionizing healthcare, accelerating drug discovery, optimizing treatments, and transforming patient outcomes. But how do we bridge the gap between innovation and real-world implementation? Join leading experts as they explore how AI-powered insights and multi-omics are driving precision medicine forward—while tackling critical challenges in regulation, access, and adoption. Don’t miss this dynamic discussion on the breakthroughs shaping the future of healthcare!